INTRODUCTION
============

Based on the results of recent, prospective randomized controlled clinical trials \[[@B1][@B2]\], laparoscopic gastrectomy has been accepted as a standard treatment for early gastric cancer in Korea, Japan, and China. Several multicenter randomized controlled trials (RCTs) \[[@B3][@B4][@B5][@B6]\] are underway, aiming to clarify the benefits of laparoscopic gastrectomy compared to open gastrectomy in terms of surgical outcomes, survival, and quality of life. Moreover, the overall morbidity and mortality rates of gastrectomy in patients with gastric cancer have decreased because of improvements in surgical skill, advancements in surgical instruments, and careful perioperative management over the past 2 decades \[[@B7]\].

However, duodenal stump leakage remains a fatal complication after gastrectomy. The reported incidence of duodenal stump leakage is between 1.6%--5.0% in Billroth II or Roux-en-Y reconstruction following gastrectomy for gastric cancer \[[@B8]\]. According to a recent multicenter study, the laparoscopic approach increased the risk of development of duodenal stump leakage, as compared to the open approach \[[@B9]\].

To date, no prospective clinical trials have been conducted for duodenal stump leakage after laparoscopic or open gastrectomy in patients with gastric cancer. We previously reported a new technique of laparoscopic reinforcement suture (LARS) on the staple line of the duodenal stump using barbed suture for prevention of duodenal stump leakage \[[@B10]\]. Herein, we describe the results of a prospective phase II study to evaluate the safety of this technique.

MATERIALS AND METHODS
=====================

Study design
------------

The estimated number of patients required for this study was 100 for a period of 18 months, because duodenal stump leakage after gastrectomy occurred in 1.1% among 1,195 patients in our experience \[[@B11]\]. We planned to discontinue the study if more than 2 cases of duodenal stump leakage occurred. Duodenal stump leakage was defined based on clinical suspicion, laboratory findings of fluid from the drain, or radiologic findings using computed tomography (CT) or fistulogram.

Inclusion criteria were histologically proven gastric adenocarcinoma treated with laparoscopic distal or total gastrectomy and Billroth II or Roux-en-Y reconstruction, and patient age of \>19 years. Patients were excluded if they had a history of previous abdominal surgery except cholecystectomy, and required combined abdominal surgery excepting cholecystectomy. Patients with gastric outlet obstruction or cancer invasion to the pylorus were also excluded.

The primary endpoint was the incidence of duodenal stump fistula within the first 30 postoperative days. The secondary endpoints were early postoperative outcomes until discharge. The study was performed under approval of the Institutional Review Board at Dong-A University Hospital (IRB No. DAUHIRB-16-010). All patients provided written informed consent before participating in the study. This study was registered at ClinicalTrials.gov (NCT03085199).

Surgical technique
------------------

For laparoscopic gastrectomy in cases of gastric cancer, 5 trocars were used while the operator stood at the patient\'s right side during the entire procedure, as described in our previous report \[[@B12]\]. After cutting the duodenal stump to about 2 cm in length using a linear stapler, LARS was commenced from the upper to the lower part on the staple line of the duodenal stump. Continuous suture with invagination of the duodenal stump was performed using a barbed suture ([Fig. 1](#F1){ref-type="fig"}). In cases of patients with a short duodenal stump owing to chronic ulcer or ectopic pancreas at the duodenal bulb, 2 or 3 interrupted sutures without invagination of the duodenal stump ([Fig. 2](#F2){ref-type="fig"}) were placed using barbed sutures.

![Continuous LARS with invagination. At the upper end of the duodenal stump, a triangular suture with a barbed suture is performed (A). Then, a reinforcement suture with invagination of the staple line is continued up to the lower end of the duodenal stump (B). At the lower end, a triangular suture with invagination is performed once again (C). After the continuous suture with invagination ends, the duodenal stump staple line is buried under the barbed suture (D).\
LARS = laparoscopic reinforcement suture.](jgc-17-354-g001){#F1}

![Interrupted LARS without invagination. From one end of the duodenal stump, interrupted sutures using barbed sutures are performed 2 or 3 times to cover the whole staple line.\
LARS = laparoscopic reinforcement suture.](jgc-17-354-g002){#F2}

Perioperative management
------------------------

All patients were managed routinely using a standardized postoperative protocol as follows: 1) no nasogastric intubation or preoperative mechanical bowel preparation; 2) minimal spillage of gastric contents during surgery; 3) injections of prophylactic antibiotics twice, at preoperative 30 minutes and postoperative 1 hour; 4) the use of one closed-suction drain; 5) sips of water at one day after the operation; 6) a clear liquid diet at 3 days after the operation; and 7) discharge at 6 or 7 days after the operation in the absence of abnormal clinical symptoms.

All operations were performed by M.C. Kim, who had conducted \>1,500 laparoscopic gastrectomies for gastric cancer since April 2003. The indication for laparoscopic gastrectomy for gastric cancer at our institute is less than preoperative stage cT2 or 3N1M0.

RESULTS
=======

Patient characteristics
-----------------------

One hundred patients were enrolled in the study between February 2016 and March 2017. There was one case of postoperative mortality, but 99 patients completed the postoperative 30-day follow-up protocol as scheduled. The demographic and clinicopathological characteristics of these patients are summarized in [Table 1](#T1){ref-type="table"}. The study group consisted of 65 men and 35 women with a mean age (years) of 62.3. Among the patients, 63 (63%) had a comorbidity, with hypertension and diabetes mellitus the most common. Most patients (n=99) underwent laparoscopic distal subtotal gastrectomy with Billroth II reconstruction. In the final pathological examination, 84 patients had stage I, 14 patients had stage II, and 2 patients had stage III cancer according to the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) tumor, node, and metastasis (TNM) classification (7th edition). The mean number of retrieved lymph nodes (LNs) was 38.

###### Demographic and clinicopathological characteristics of patients

![](jgc-17-354-i001)

  Characteristics         Patients (n=100)              
  ----------------------- ----------------------------- ---------
  Age (yr)                62.3±11.3                     
  Gender                                                
                          Male                          65
                          Female                        35
  BMI (kg/m^2^)           24.0±3.1                      
  ASA status                                            
                          1                             11
                          2                             63
                          3                             26
  Comorbidity             63                            
  Extent of resection                                   
                          Distal subtotal gastrectomy   99
                          Total gastrectomy             1
  Reconstruction                                        
                          Billroth II                   99
                          Roux-en-Y                     1
  Tumor depth                                           
                          T1a                           40
                          T1b                           41
                          T2                            10
                          T3                            8
                          T4a                           1
  Nodal metastasis                                      
                          N0                            82
                          N1                            12
                          N2                            2
                          N3                            4
  Harvested LNs           38.6±12.9                     
  Resection margin (cm)                                 
                          Proximal                      5.8±2.7
                          Distal                        6.9±3.3

All values are mean with standard deviation.

BMI = body mass index; ASA = American Society of Anesthesiologists; LN = lymph node.

Surgical outcomes and operative complication
--------------------------------------------

No duodenal stump leakage was observed in any of the study patients. All patients underwent D2 LN dissection with partial omentectomy. The mean operation time was 145 minutes including 7.8 minutes of mean LARS time ([Fig. 3](#F3){ref-type="fig"}). LARS with invagination of the duodenal stump was successfully performed in 99 patients ([Table 2](#T2){ref-type="table"}). Complications developed in 13 cases, with one reoperation for splenic artery rupture. Only 3 patients experienced complications above grade IIIa based on the Clavien-Dindo classification, and one 80-year-old male patient who suffered from idiopathic pulmonary fibrosis preoperatively died of pulmonary failure at postoperative 27 days ([Table 3](#T3){ref-type="table"}).

![Operation time of LARS in 100 patients. The mean time for LARS is 7.8 minutes. The 95% confidence interval for the mean is 7.3674 to 8.2106.\
LARS = laparoscopic reinforcement suture.](jgc-17-354-g003){#F3}

###### Surgical outcomes

![](jgc-17-354-i002)

  Outcomes                             Patients (n=100)   
  ------------------------------------ ------------------ ----
  Operation time (min)                 145±29.5           
  LARS time (min)                      7.8±2.1 (5--17)    
  LARS type                                               
                                       Invagination       99
                                       Non-invagination   1
  Intraoperative bleeding loss (mL)    50±43.3            
  Postoperative hospital stays (day)   7.5±2.0            
  Morbidity                            13                 
  Mortality                            1                  

All values are mean with standard deviation.

LARS = laparoscopic reinforcement suture.

###### Morbidity and mortality
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                                                 Patients (n=100)          
  ---------------------------------------------- ------------------------- ---
  Postoperative complication                                               
                                                 Duodenal stump leakage    0
                                                 Wound complication        1
                                                 Intraabdominal bleeding   1
                                                 Intraluminal bleeding     2
                                                 Paralytic ileus           2
                                                 Gastric stasis            2
                                                 Acute pancreatitis        1
                                                 Hepatopathy               1
                                                 Colitis                   1
                                                 Infectious arthritis      1
                                                 Pulmonary failure         1
  Clavien-Dindo classification of complication                             
                                                 I                         3
                                                 II                        7
                                                 IIIa                      1
                                                 IIIb                      1
                                                 IV                        0
                                                 V                         1

DISCUSSION
==========

In 1992, Kitano et al. \[[@B13]\] first introduced laparoscopic gastrectomy for gastric cancer; thereafter, the Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) group contributed to the rapid adaptation of laparoscopic gastrectomy for patients with gastric cancer through active learning and education, workshops, and international academic communication \[[@B6]\]. To provide some clinical evidence for laparoscopic gastrectomy for gastric cancer, a retrospective multicenter cohort study including 3,053 patients with gastric cancer was conducted. Based on this database, numerous studies were published to compare open vs. laparoscopic gastrectomy in terms of various aspects such as postoperative complications \[[@B14]\], residual cancer after endoscopic mucosal resection \[[@B15]\], advanced patient age \[[@B16]\], obesity \[[@B17]\], recurrence \[[@B18]\], and survival \[[@B19][@B20]\]. Subsequently, the 2 most important RCTs, laparoscopic vs. open distal gastrectomy for clinical stage I gastric cancer: KLASS-01 \[[@B1]\] and locally advanced gastric cancer: KLASS-02 \[[@B4]\] were conducted. Recently, laparoscopic gastrectomy has been commonly performed for the treatment of patients with not only early but also advanced gastric cancer in Korea, Japan, and China.

However, open gastrectomy with LN dissection remains a challenging surgery with a high morbidity rate in the West. The morbidity and mortality rates of 2 western RCTs \[[@B21][@B22]\] were 25%--46% and 4%--13%, respectively. Regarding laparoscopic gastrectomy, 2 large-scale retrospective multicenter trials \[[@B14][@B23]\] in the East demonstrated a 14% morbidity rate and a \<1% mortality rate. Several small-sized retrospective single center trials \[[@B24][@B25][@B26]\] of laparoscopic gastrectomy in the West reported an 8%--23% morbidity rate and a 2.0%--3.5% mortality rate, respectively. The differences in reported postoperative morbidity and mortality between the East and West are most likely attributable to differences in patient characteristics as well as the stage and incidence of gastric cancer. Despite the existence of several specialized high-volume centers in the East, anastomotic leakage after laparoscopic gastrectomy for gastric cancer reportedly occurred in 1%--2% of patients \[[@B14][@B24]\]. Among the types of anastomotic leakages, duodenal stump leakage can be the most serious complication because of impending sepsis or death, despite the performance of re-exploration surgery for duodenal stump leakage.

Patient age, comorbidities, nutritional status, chronic ulcer, or ectopic pancreas on duodenal bulb, cancer invasion to pylorus, or gastric outlet obstruction could be considered risk factors associated with duodenal stump leakage after gastrectomy \[[@B8][@B9]\]. In addition, precise and careful surgical technique around the duodenum should be recommended for prevention of thermal injury of the duodenum, pancreas, and vessels during laparoscopic gastrectomy. Surgeons had previously become interested in several reinforcement methods for the prevention of staple line leakage in patients with morbid obesity undergoing sleeve gastrectomy. Reinforcement methods for the staple line included various applications of absorbable membrane or bovine pericardium, and suturing on the staple line. Among these approaches, the lowest leakage rate was achieved after reinforcement on the staple line using absorbable membrane or oversewing the suture line \[[@B27]\]. Based on a systematic review and a large retrospective study \[[@B8][@B28]\], conservative treatment for duodenal stump leakage was determined to be the treatment of choice, eventually associated with percutaneous drainage or percutaneous transhepatic biliary drainage (PTBD) \[[@B29]\]. Re-exploration is recommended in severe cases or for patients who do not respond to conservative treatment.

Reinforcement suturing of the staple line after cutting the duodenum has commonly been performed for prevention of duodenal stump leakage in patients undergoing open gastric surgery. LARS on the staple line of the duodenal stump using barbed suture in laparoscopic gastrectomy for gastric cancer was developed and established in 62 consecutive patients from July 2016 to January 2017 at our institute \[[@B10]\]. Subsequently, the current prospective phase II study was planned for evaluation of the safety of LARS in 100 patients. LARS on the staple line of the duodenal stump using barbed suture includes the invagination and non-invagination types. Non-invagination LARS was chosen when the length of the duodenal stump after cutting was \<1 cm. In the present study, there was no occurrence of any intraoperative or postoperative complications related to LARS.

Based on the findings of this prospective phase II study, LARS can be safely conducted in a short operation period without development of duodenal stump leakage. A randomized prospective controlled trial is required to confirm the surgical benefit of LARS in comparison to non-LARS.
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